Tesamorelin
Listing ID#164427
Model00002
CategoryChemicals

Tesamorelin

Specifications

Origin
China
Packaging
foil abg
Price Term
EXW/EX-Work,FOB
Payment Term
T/T,L/C,Western Union
Request Quote
Quick answer

Tesamorelin is a Chemicals product. Key specs — Origin: China; Packaging: foil abg; Price Term: EXW/EX-Work,FOB; Payment Term: T/T,L/C,Western Union.

Product Description

Tesamorelin

MF: C221H366N72O67S MW: 5135.77794 Purity: 99% Specification: 2mg/vial Appearance: White Lyophilized Powder Place of Origin: China Certification: SGS Method of Analysis: HPLC Storage: Lyophilized peptides although stable at room temperature for 3 months, should be stored desiccated below -18° C. Upon reconstitution of the peptide it should be stored at 4° C between 2-21 days and for future use below -18° C.

Product description Tesamorelin is a synthetic peptide consisting of all 44 amino acids of hGRF with the addition of a trans-3-Hexenoic acid group.

Tesamorelin (also known as Egrifta) is a synthetic form of growth-hormone-releasing hormone which is used in the treatment of HIV-associated lipodystrophy.

Tesamorelin has been shown to reduce lipodystrophy in HIV-infected individuals. Lipodystrophy is a condition that causes changes in placement of body fat, including wasting and fat accumulation, and changes in metabolism.

Similar to Tesamorelin is Sermorelin, which may be taken with GHRP-6 is clinical trials, that also promotes production and possible fat loss. Individuals with lipodystrophy may develop excess fat most notably around the liver, stomach, and other abdominal organs (visceral body fat).

Application

Tesamorelin (also known as Egrifta) is a synthetic form which is used in the treatment of HIV-associated lipodystrophy. Tesamorelin has been shown to reduce lipodystrophy in HIV-infected individuals. Lipodystrophy is a condition that causes changes in placement of body fat, including wasting and fat accumulation, and changes in metabolism.

Similar to Tesamorelin is Sermorelin, which may be taken with GHRP-6 is clinical trials, that also promotes production and possible fat loss. Individuals with lipodystrophy may develop excess fat most notably around the liver, stomach, and other abdominal organs (visceral body fat).

Other peptides: Name Specification T-A001 MGF 2mg/vial T-A002 PEG MGF 2mg/vial T-A003 CJC-1295 with DAC 2mg/vial T-A004 CJC-1295 without DAC 2mg/vial T-A005 PT-141 10mg/vial T-A006 MT-1(Melanotan) 10mg/vial T-A007 MT-2 10mg/vial T-A008 GHRP-2 5mg/vial T-A008 GHRP-2 10mg/vial T-A009 GHRP-6 5mg/vial T-A009 GHRP-6 10mg/vial T-A010 Ipamorelin 2mg/vial T-A011 Hexarelin 2mg/vial T-A012 Sermorelin 2mg/vial T-A013 Oxytocin 2mg/vial T-A014 TB500 2mg/vial T-A015 pentadecapeptide BPC 157 2mg/vial T-A016 HGH 176-191 2mg/vial T-A017 Triptorelin 2mg/vial T-A018 Tesamorelin 2mg/vial T-A020 Gonadorelin 2mg/vial T-A020 Gonadorelin 10mg/vial T-A021 DSIP 2mg/vial T-A022 Selank 5mg/vial

Related Products